Needham & Company Raises Price Target on Faro Technologies (FARO) to $39 Following 2nd Consecutive Beat

Go back to Needham & Company Raises Price Target on Faro Technologies (FARO) to $39 Following 2nd Consecutive Beat

Unusual 11 Mid-Day Movers 5/4: (EBIO) (GKOS) (QUAD) Higher; (FSTR) (DXYN) (CRAY) Lower

May 4, 2016 12:58 PM EDT

Eleven Biotherapeutics (Nasdaq: EBIO) 34.7% HIGHER; gaining for the second session after the company presented new data from post hoc analyses on the influence of Interleukins IL-1 genetic patterns on response to isunakinra (EBI-005) in severe allergic conjunctivitis and severe dry eye study subjects.

L.B. Foster (Nasdaq: FSTR) 28.2% LOWER; reported Q1 EPS of ($0.28), $0.20 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $126.3 million versus the consensus estimate of $128.9 million.

Glaukos Corporation (NYSE:... More

Faro Technologies (FARO) Tops Q1 EPS by 15c

May 3, 2016 4:40 PM EDT

Faro Technologies (NASDAQ: FARO) reported Q1 EPS of $0.19, $0.15 better than the analyst estimate of $0.04. Revenue for the quarter came in at $75.7 million versus the consensus estimate of $71.74 million.

For earnings history and earnings-related data on Faro Technologies (FARO) click here.

... More